Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Safety and Efficacy of Lipiodol® Ultra Fluid in Association With Surgical Glues During Vascular Embolization

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02625389
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:11.883597+00:00
Published At
2025-10-10T00:00:00+00:00
Record Updated At
2025-10-10
Results Posted At
2025-10-10
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Congenital Hemangioma", "Hemangioendothelioma", "Angiosarcoma", "Arteriovenous Malformations"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-10-10"
protocolSection.identificationModule.nctId
"NCT02625389"
protocolSection.identificationModule.officialTitle
"Safety and Efficacy of Lipiodol\u00ae Ultra Fluid in Association With Surgical Glues During Vascular Embolization"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2025-10-10"

Study condition terms

  • Congenital Hemangioma (protocolSection.conditionsModule.conditions)
  • Hemangioendothelioma (protocolSection.conditionsModule.conditions)
  • Angiosarcoma (protocolSection.conditionsModule.conditions)
  • Arteriovenous Malformations (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.